Literature DB >> 2645360

Distribution of the beta 1 subgroup of the integrins in human cells and tissues.

B De Strooper1, B Van der Schueren, M Jaspers, M Saison, M Spaepen, F Van Leuven, H Van den Berghe, J J Cassiman.   

Abstract

We studied the distribution of the beta 1 integrin subfamily in human tissues and cells by light microscopy, electron microscopy, and immunoblotting, using monoclonal antibody DH12, previously shown to react with the beta 1 subunit of the human fibronectin receptor. Crossreaction with the other beta subunits of the integrin family, which have 45% and 47% primary amino acid sequence identity with the beta 1 subunit, was excluded, as MAb DH12 did not react with the beta 2 subunit in granulocytes and the beta 3 subunit in thrombocytes. Reactivity with the anti-beta 1 antibody was found in skin, lung, heart, striated and smooth muscle, blood cells, liver, kidney, intestine, spleen and placenta. Thus, cells of mesodermal, ectodermal, and entodermal origin express the beta 1 subunit. In skin fibroblasts cultured in vitro, beta 1 subunit was also detected intracellularly. The wide distribution of the beta 1 family, originally detected in activated T-lymphocytes after prolonged culture in vitro, contrast with the restricted distribution of the beta 2 integrins on leucocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645360     DOI: 10.1177/37.3.2645360

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  16 in total

1.  Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells.

Authors:  B Kreft; R Marre; U Schramm; R Wirth
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Cell adhesion molecules in oesophageal epithelium.

Authors:  H Dobson; M Pignatelli; D Hopwood; C D'Arrigo
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

3.  Invasin-dependent and invasin-independent pathways for translocation of Yersinia pseudotuberculosis across the Peyer's patch intestinal epithelium.

Authors:  A Marra; R R Isberg
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Fibronectin attachment protein homologue mediates fibronectin binding by Mycobacterium avium subsp. paratuberculosis.

Authors:  T E Secott; T L Lin; C C Wu
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas.

Authors:  J Peltonen; H Larjava; S Jaakkola; H Gralnick; S K Akiyama; S S Yamada; K M Yamada; J Uitto
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

6.  Polymorphonuclear leucocyte migration through human dermal fibroblast monolayers is dependent on both beta 2-integrin (CD11/CD18) and beta 1-integrin (CD29) mechanisms.

Authors:  J X Gao; A C Issekutz
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

7.  Adult adenohypophysial cells express beta 1 integrins and prefer laminin during cell-substratum adhesion.

Authors:  M J Horacek; T Kawaguchi; L Terracio
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-01       Impact factor: 2.416

8.  Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis.

Authors:  A Laffón; R García-Vicuña; A Humbría; A A Postigo; A L Corbí; M O de Landázuri; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

9.  Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human epidermal keratinocytes and non-differentiating keratinocytes.

Authors:  J C Adams; F M Watt
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

10.  Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle.

Authors:  A J North; B Galazkiewicz; T J Byers; J R Glenney; J V Small
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.